See also this year's filing and all EDGAR filings for this company.
PDF Report 0001513525_2024_Adial_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001513525, Adial Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,198,679 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 1,537,926 |
| 4 | LiabilitiesCurrent | 653,076 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,479,308 |
| 9 | ResearchAndDevelopmentExpense | -2,979,797 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,212,341 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 4,736,605 |
| 1 | Liabilities | 653,076 |
| 2 | Expenses | 2,499,511 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 4,083,529 |
| 5 | NetIncome | -1,287,170 |
| 6 | ComprehensiveNetIncome | -1,287,170 |
| 7 | BaseVar | 4,550,766 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.83 |
| 9 | EconomicCapitalRatio | 3.57 |
Edgar->Model Mapping
Feature Distribution
Change over Time
